CD133-Targeted Natural Killer Cell Therapy for Aggressive Variant Prostate Cancer

Project: Research project

Project Details

Description

CD133-Targeted Natural Killer Cell Therapy for Aggressive Variant Prostate Cancer
StatusFinished
Effective start/end date12/31/184/30/21

Funding

  • PROSTATE CANCER FOUNDATION

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.